New publication! Biomedicine & Pharmacotherapy 2024; 175: 116660 (SCI; IF=7.5; Rank = 7.9% by IF in Pharmacology & Pharmacy; USA and Taiwan patent application: under review)

BP 2024 announcementExploring In Vivo Combinatorial Chemo-Immunotherapy: Addressing p97 Suppression and Immune Reinvigoration in Pancreatic Cancer with Tumor Microenvironment-Responsive Nanoformulation. Biomedicine & Pharmacotherapy 2024; 175: 116660 (SCI; IF=7.5; Rank = 7.9% by IF in Pharmacology & Pharmacy; USA and Taiwan patent application: under review).